Cargando…

Human-in-the-loop assisted de novo molecular design

A de novo molecular design workflow can be used together with technologies such as reinforcement learning to navigate the chemical space. A bottleneck in the workflow that remains to be solved is how to integrate human feedback in the exploration of the chemical space to optimize molecules. A human...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundin, Iiris, Voronov, Alexey, Xiao, Haoping, Papadopoulos, Kostas, Bjerrum, Esben Jannik, Heinonen, Markus, Patronov, Atanas, Kaski, Samuel, Engkvist, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795720/
https://www.ncbi.nlm.nih.gov/pubmed/36578043
http://dx.doi.org/10.1186/s13321-022-00667-8
_version_ 1784860322470821888
author Sundin, Iiris
Voronov, Alexey
Xiao, Haoping
Papadopoulos, Kostas
Bjerrum, Esben Jannik
Heinonen, Markus
Patronov, Atanas
Kaski, Samuel
Engkvist, Ola
author_facet Sundin, Iiris
Voronov, Alexey
Xiao, Haoping
Papadopoulos, Kostas
Bjerrum, Esben Jannik
Heinonen, Markus
Patronov, Atanas
Kaski, Samuel
Engkvist, Ola
author_sort Sundin, Iiris
collection PubMed
description A de novo molecular design workflow can be used together with technologies such as reinforcement learning to navigate the chemical space. A bottleneck in the workflow that remains to be solved is how to integrate human feedback in the exploration of the chemical space to optimize molecules. A human drug designer still needs to design the goal, expressed as a scoring function for the molecules that captures the designer’s implicit knowledge about the optimization task. Little support for this task exists and, consequently, a chemist usually resorts to iteratively building the objective function of multi-parameter optimization (MPO) in de novo design. We propose a principled approach to use human-in-the-loop machine learning to help the chemist to adapt the MPO scoring function to better match their goal. An advantage is that the method can learn the scoring function directly from the user’s feedback while they browse the output of the molecule generator, instead of the current manual tuning of the scoring function with trial and error. The proposed method uses a probabilistic model that captures the user’s idea and uncertainty about the scoring function, and it uses active learning to interact with the user. We present two case studies for this: In the first use-case, the parameters of an MPO are learned, and in the second use-case a non-parametric component of the scoring function to capture human domain knowledge is developed. The results show the effectiveness of the methods in two simulated example cases with an oracle, achieving significant improvement in less than 200 feedback queries, for the goals of a high QED score and identifying potent molecules for the DRD2 receptor, respectively. We further demonstrate the performance gains with a medicinal chemist interacting with the system. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00667-8.
format Online
Article
Text
id pubmed-9795720
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97957202022-12-29 Human-in-the-loop assisted de novo molecular design Sundin, Iiris Voronov, Alexey Xiao, Haoping Papadopoulos, Kostas Bjerrum, Esben Jannik Heinonen, Markus Patronov, Atanas Kaski, Samuel Engkvist, Ola J Cheminform Research A de novo molecular design workflow can be used together with technologies such as reinforcement learning to navigate the chemical space. A bottleneck in the workflow that remains to be solved is how to integrate human feedback in the exploration of the chemical space to optimize molecules. A human drug designer still needs to design the goal, expressed as a scoring function for the molecules that captures the designer’s implicit knowledge about the optimization task. Little support for this task exists and, consequently, a chemist usually resorts to iteratively building the objective function of multi-parameter optimization (MPO) in de novo design. We propose a principled approach to use human-in-the-loop machine learning to help the chemist to adapt the MPO scoring function to better match their goal. An advantage is that the method can learn the scoring function directly from the user’s feedback while they browse the output of the molecule generator, instead of the current manual tuning of the scoring function with trial and error. The proposed method uses a probabilistic model that captures the user’s idea and uncertainty about the scoring function, and it uses active learning to interact with the user. We present two case studies for this: In the first use-case, the parameters of an MPO are learned, and in the second use-case a non-parametric component of the scoring function to capture human domain knowledge is developed. The results show the effectiveness of the methods in two simulated example cases with an oracle, achieving significant improvement in less than 200 feedback queries, for the goals of a high QED score and identifying potent molecules for the DRD2 receptor, respectively. We further demonstrate the performance gains with a medicinal chemist interacting with the system. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00667-8. Springer International Publishing 2022-12-28 /pmc/articles/PMC9795720/ /pubmed/36578043 http://dx.doi.org/10.1186/s13321-022-00667-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sundin, Iiris
Voronov, Alexey
Xiao, Haoping
Papadopoulos, Kostas
Bjerrum, Esben Jannik
Heinonen, Markus
Patronov, Atanas
Kaski, Samuel
Engkvist, Ola
Human-in-the-loop assisted de novo molecular design
title Human-in-the-loop assisted de novo molecular design
title_full Human-in-the-loop assisted de novo molecular design
title_fullStr Human-in-the-loop assisted de novo molecular design
title_full_unstemmed Human-in-the-loop assisted de novo molecular design
title_short Human-in-the-loop assisted de novo molecular design
title_sort human-in-the-loop assisted de novo molecular design
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795720/
https://www.ncbi.nlm.nih.gov/pubmed/36578043
http://dx.doi.org/10.1186/s13321-022-00667-8
work_keys_str_mv AT sundiniiris humanintheloopassisteddenovomoleculardesign
AT voronovalexey humanintheloopassisteddenovomoleculardesign
AT xiaohaoping humanintheloopassisteddenovomoleculardesign
AT papadopouloskostas humanintheloopassisteddenovomoleculardesign
AT bjerrumesbenjannik humanintheloopassisteddenovomoleculardesign
AT heinonenmarkus humanintheloopassisteddenovomoleculardesign
AT patronovatanas humanintheloopassisteddenovomoleculardesign
AT kaskisamuel humanintheloopassisteddenovomoleculardesign
AT engkvistola humanintheloopassisteddenovomoleculardesign